Literature DB >> 15105647

Malignant mesonephric tumors of the female genital tract: a clinicopathologic study of 9 cases.

Silvia Bagué1, Ingrid M Rodríguez, Jaime Prat.   

Abstract

Nine malignant mesonephric tumors were obtained from the consultation files of one of the authors (J.P.) over a 13-year period (1988-2001). There were 4 adenocarcinomas (ACs) and 5 malignant mixed mesonephric tumors (MMMTs). The ACs were found in the cervix (3) and vagina (1). The MMMTs involved the uterus (1), cervix (3), and vagina (1). Most patients presented with abnormal vaginal bleeding. The 4 patients with mesonephric AC ranged in age from 24 to 54 years (mean, 41 years). The tumors measured 2 to 6 cm (mean, 3.7 cm). Two ACs were stage I and two were stage II. Two of the three patients with follow-up information were alive without clinical evidence of disease at 3 and 11.5 years, and the other was alive with recurrent tumor 8.5 years postoperatively. The 5 patients with MMMTs ranged in age from 37 to 62 years (mean, 49 years). The mean size of four tumors was 5.2 cm (range, 3.5-8 cm). The uterine MMMT infiltrated the entire myometrial wall extending to the endometrial cavity where it resembled an endometrial polyp. Although the most common histologic pattern in the current series was the glandular (ductal) pattern, retiform, tubular, and solid growth patterns were also encountered. Among the MMMT subgroup, the sarcomatous component was homologous in 3 cases (endometrial stromal or spindle cell) and heterologous in the other 2 cases (skeletal muscle and cartilage). Of the 4 patients with follow-up information available, 1 (stage II) died of disease 7 months after surgery, another (stage IV) was alive with bone metastases at 3.3 years, and the other 2 patients (stages IB and IC) had no clinical evidence of disease at 1 and 3.7 years, respectively. Evidence of mesonephric hyperplasia was found in 5 (42%) cases. The MMMT that arose in the corpus presented as an endometrial polyp. In this case, histologic differential diagnosis includes serous carcinoma, endometrial stromal sarcoma, and uterine tumor resembling ovarian sex cord-stromal tumor. Immunostainings are not helpful. Mesonephric ACs often present in early stage and have better prognosis than their müllerian counterparts. Surgery alone appears to be the treatment of choice. In contrast, MMMTs may present in advanced stage and are aggressive tumors, similar to malignant mixed müllerian tumors.

Entities:  

Mesh:

Year:  2004        PMID: 15105647     DOI: 10.1097/00000478-200405000-00006

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  24 in total

1.  Carcinosarcoma of the uterine cervix: a rare pathological finding originating from mesonephric remnants.

Authors:  Bárbara Ribeiro; Raquel Silva; Renata Dias; Vanda Patrício
Journal:  BMJ Case Rep       Date:  2019-03-31

2.  Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.

Authors:  Simona Stolnicu; Iulia Barsan; Lien Hoang; Prusha Patel; Luis Chiriboga; Cristina Terinte; Anna Pesci; Sarit Aviel-Ronen; Takako Kiyokawa; Isabel Alvarado-Cabrero; Malcolm C Pike; Esther Oliva; Kay J Park; Robert A Soslow
Journal:  Am J Surg Pathol       Date:  2018-08       Impact factor: 6.394

3.  Mesonephric adenocarcinoma of the uterine corpus.

Authors:  Haixia Wu; Lin Zhang; Wenfeng Cao; Yuanjing Hu; Yixin Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 4.  Mesonephric adenocarcinoma of the uterine cervix and literature review.

Authors:  Antonios Anagnostopoulos; Stuart Ruthven; Robert Kingston
Journal:  BMJ Case Rep       Date:  2012-12-10

Review 5.  [Ectopic tissue of the female genital tract].

Authors:  F Otterbach; D Schmidt
Journal:  Pathologe       Date:  2018-09       Impact factor: 1.011

6.  Mixed Mesonephric Adenocarcinoma and High-grade Neuroendocrine Carcinoma of the Uterine Cervix: Case Description of a Previously Unreported Entity With Insights Into Its Molecular Pathogenesis.

Authors:  Marcela S Cavalcanti; Anne M Schultheis; Caleb Ho; Lu Wang; Deborah F DeLair; Britta Weigelt; Ginger Gardner; Stuart M Lichtman; Meera Hameed; Kay J Park
Journal:  Int J Gynecol Pathol       Date:  2017-01       Impact factor: 2.762

7.  Carcinosarcoma of the uterine cervix arising from Müllerian ducts.

Authors:  Myounghwan Kim; Chulmin Lee; Hoon Choi; Ji-Kyung Ko; Guhyun Kang; Kyoung-Chul Chun
Journal:  Obstet Gynecol Sci       Date:  2015-05-19

8.  Mesonephric adenocarcinoma of the vagina masquerading as a suburethral cyst.

Authors:  Samar Shoeir; Aswini Aparna Balachandran; Jayson Wang; Abdul H Sultan
Journal:  BMJ Case Rep       Date:  2018-07-03

9.  Mesonephric adenocarcinoma of the uterine cervix with rare lung metastases: A case report and review of the literature.

Authors:  Li-Li Jiang; De-Ming Tong; Zi-Yi Feng; Kui-Ran Liu
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

10.  Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract.

Authors:  Jelena Mirkovic; Lynette M Sholl; Elizabeth Garcia; Neal Lindeman; Laura MacConaill; Michelle Hirsch; Paola Dal Cin; Melissa Gorman; Justine A Barletta; Marisa R Nucci; W Glenn McCluggage; Brooke E Howitt
Journal:  Mod Pathol       Date:  2015-09-04       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.